As children, we all heard the story of the Tooth Fairy: when baby teeth fall out, new ones grow. But what if this ability could be achieved again in adulthood?
Imagine being able to grow natural teeth again, without relying on implants – it sounds like science fiction, but it is now becoming a reality.
Japanese researchers are taking a key step towards this goal. They plan to start human trials in September this year to test an antibody drug designed to promote the natural regeneration of teeth.
If all goes well, the drug could be officially launched in 2030. The research team hopes to eventually help those who are suffering from congenital tooth loss or tooth loss later in life.
“We hope to bring new hope to those who suffer from tooth loss,” said Masaru Takahashi, director of dentistry at the Institute of Medical Research at Kitano Hospital in Osaka, in an interview with the Mainichi Shimbun. “Although there is no cure at present, society’s expectations for tooth regeneration have been high.”
The research was led by Toregem Biopharma, which has developed an antibody drug that acts on undeveloped “tooth buds” in the mouths of adults to activate their potential to grow teeth again.
The initial study will focus on patients with congenital missing teeth, and in the future it is hoped that it will be extended to a wider range of toothless people.
Patients with congenital missing teeth have tooth germs in their mouths that cannot erupt, and scientists believe that this provides a basis for activating their natural growth.
Dr. Victoria Weitzman, a cosmetic dentist in New York, said that this breakthrough “may completely change the way we treat patients.”
She pointed out that the function of natural teeth is far better than any artificial substitute, and tooth regeneration technology may become the new standard of dental treatment in the future.
This prospect also makes many patients full of expectations. “Patients are already asking me if they can skip surgery and grow natural teeth directly,” shared Dr. Salvatore La Mastra, a dentist in Dallas, Texas. “This technology has definitely aroused great interest.”
Currently, the drug has successfully caused mice and ferrets to grow new teeth. However, there is still a long way to go from animal experiments to widespread application in humans.
“This research is very interesting and promising, but there are still many challenges before it can be widely used in the clinic,” Dr. La Mastra pointed out.
He added that tooth regeneration involves far more complex physiological mechanisms than we can imagine. “There are billions of signaling pathways in our bodies, and it is very difficult to find and activate the right one and ensure consistent and predictable results,” said Dr. Weitzman.
In addition, regenerating teeth also has potential risks. Activating tooth buds incorrectly may result in the wrong position or type of tooth, such as a molar where an incisor is needed, which not only affects the bite, but may also cause pain or require restoration.
Although this technology is unlikely to replace mature dental implant technology in the short term, the prospects are still exciting. “Regenerative medicine is the future of medicine,” said Dr. Weitzman.
“With the participation of artificial intelligence in biological research, we have accelerated the research process. This is a very exciting time in medicine and health.”
It may still take a few years for tooth regeneration to actually enter the dental clinic, but this change has quietly started. For the millions of people around the world who have lost their teeth, this is a hopeful sign worth paying attention to.